Arterial Thrombosis After Using Angio-Seal

Risk Factors for Puncture Site Complications After Endovascular Procedures in Patients With Peripheral Arterial Disease

“…6 Moreover, studies show that the use of vascular closure devices, especially devices where a foreign body is left inside the vessel, may lead to more severe complications. [13][14][15][16] We were able to identify risk factors for development of complications at femoral access sites. Age is a known risk factor for vascular complications in percutaneous coronary interventions, perhaps related to the presence of more severe atherosclerosis and multiple comorbidities in the elderly individuals.…”

A New Hemostasis Tool after Percutaneous Angioplasty: The Hemcontm Pad Hemostasis Device

“…In the last decade, Angio-SealTM hemostatic puncture closure device is intended for use in sealing the defect in the puncture site wall produced by percutaneous access [5]. The use of this closure device significantly improves patients' and physicians' comfort, however, this device also have been reported to increase thrombosis complications [6]. Recently, chitosan -a polymer of poly-d-glucosamine and polyn-acetyl-d-glucosamine found in the crustaceans have been shown effective in promoting hemostasis [7].…”

Access and Hemostasis: Femoral and Popliteal Approaches and Closure Devices—Why, What, When, and How?

“…If a closure device is being considered in close proximity to a stent, an extravascular VCD (Mynx, Exoseal, and Starclose) is probably safest to use to minimize the risk of a vessel locator getting entangled in the stent struts. [78][79][80] Outside the CFA Use of VCD outside of the CFA is "off label," and should be discussed with the patient. The use of active VCDs for closure of popliteal or brachial access has been anecdotally reported, although only with entirely extravascular devices because of the small size (< 5 mm) of these arteries.…”